Globus Medical (GMED) PT Raised to $103 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Truist Securities Reiterates Hold Rating on Globus Medical (GMED)
February 24, 2025 2:46 PM ESTTruist Securities analyst Richard Newitter reiterated a Hold rating and $90.00 price target on Globus Medical (NYSE: GMED)
The analyst comments "GMED's relatively broad/clean 4Q beat was somewhat clouded by ongoing q's re: the unexpected NVRO deal (announced 2/6 [HERE]). We think... More
